ITMN Related Analyst Ratings
-
Wedbush Assumes and Initiates Coverage on Several Key Biotech Players in Anti-Viral Space
-
ThinkEquity Downgrades InterMune (ITMN) to Source of Funds
-
Merriman Curhan Initiates Coverage on InterMune (ITMN) with a Buy
-
UBS Upgrades InterMune (ITMN) to Neutral
-
UBS Downgrades Intermune (ITMN) to Sell
-
ThinkPanmure Initiates Coverage on InterMune (ITMN) with an Accumulate
-
Natixis Bleichroeder Upgrades InterMune (ITMN) to Buy
-
Natixis Bleichroeder Starts InterMune (ITMN) at Hold
-
JMP Starts InterMune (ITMN) at Market Outperform
-
Baird Initiates Coverage on InterMune (ITMN) with a Neutral
-
Thomas Weisel Upgrades InterMune (ITMN) to Overweight
-
Jefferies & Co Upgrades InterMune (ITMN) to Hold
-
UBS Initiates Coverage on InterMune (ITMN) with a Neutral
-
Goldman Sachs Puts Buy Rating on InterMune (ITMN)
-
JP Morgan Starts InterMune (ITMN) at Overweight
-
Lazard Capital Starts InterMune (ITMN) at Buy
-
Banc of America Starts InterMune (ITMN) with a Buy
-
Jefferies & Co Downgrades InterMune (ITMN) to Underperform
-
Leerink Swann upgrades InterMune Inc. (ITMN) to Outperform
-
Wachovia upgrades InterMune (ITMN) to Outperform
-
CIBC Starts InterMune (ITMN) at Sector Outperform
-
Deutsche Bank upgrades InterMune (ITMN) to Buy
-
Maxim Group Initiates Coverage on InterMune (ITMN) with a Hold
-
Wachovia downgrades ITMN to Market Perform - Bloomberg
-
Wachovia downgrades ITMN to Underperform
-
Stiefel Nicolaus downgrades ITMN to Sell
-
Wachovia upgrades ITMN to Outperform
-
Wachovia Upgrades ITMN
-
Jefferies Initiates ITMN
-
Wachovia Downgrades ITMN
-
ThinkEquity Started ITMN at Buy
Back to ITMN Stock Lookup
